Skip to content

An Adhesion Reduction Plan in the Management of the Surgical Open Abdomen

Effect of an Adhesion Reduction Plan on Enteric Adhesions, Obstruction, and Fistulae in the Management of the Surgical Open Abdomen: A Prospective, Randomized Clinical Trial in Trauma and Emergency General Surgery

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01010464
Enrollment
0
Registered
2009-11-10
Start date
2011-01-31
Completion date
2012-08-31
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Abdomen

Keywords

Adhesions, Open abdomen, Laparotomy

Brief summary

The purpose of this study is to determine whether an adhesion reduction plan, consisting of early adhesion prevention and application of a bioresorbable membrane is effective in reducing the severity of adhesions and the incidence of complications in managing the open abdomen in trauma and emergency general surgery.

Detailed description

Adhesions are a common consequence of abdominal surgery. Trauma and emergency general surgery patients may require an open abdomen and undergo a series of abdominal operations, which may be increasingly complicated by the presence of adhesions. Adhesions appear soon after the initial operation and gradually mature within days. The effects of adhesion development on subsequent surgery may include: increased procedure time; difficulty differentiating, exposing, and accessing tissue planes; and increased risk of inadvertent enterotomy. Complications of adhesions include enteric obstruction and enterocutaneous fistulae. This study will determine whether an adhesion reduction plan, consisting of early adhesion prevention and application of a bioresorbable membrane is effective in reducing the extent and severity of adhesions and the incidence of complications in managing the open abdomen in trauma and emergency general surgery.

Interventions

PROCEDUREAdhesion Reduction Plan

Lysis of adhesions and application of a minimum of 4 sheets of a sodium hyaluronate-based bioresorbable membrane

Sponsors

Genzyme, a Sanofi Company
CollaboratorINDUSTRY
University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Trauma patients with open abdomen after initial laparotomy * Emergency surgery patients with open abdomen after initial laparotomy * Able to obtain consent from patient or LAR before any research initiated

Exclusion criteria

* Seprafilm application at initial laparotomy * Patient is a prisoner * Inability to obtain informed consent * Consentable person does not speak English

Design outcomes

Primary

MeasureTime frame
Extent and severity of adhesionsEach abdominal re-entry and re-exploration

Secondary

MeasureTime frame
Time for lysis of adhesionsEach abdominal re-entry and re-exploration
Incidence of complicationsHospital admission

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026